Kalvista Pharmaceuticals Inc (KALV) — Capital Reinvestment Ratio
Latest as of January 2018:
0.01x
Kalvista Pharmaceuticals Inc (KALV) has a Capital Reinvestment Ratio of 0.01x as of January 2018, meaning it reinvests 0% of its operating cash flow ($28.22 Million) in capital expenditures ($182.00K). See KALV cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$28.22 Million
USD
Capital Expenditures
$182.00K
USD
Data as of
Jan 2018
Most recent filing
Kalvista Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2018)
This chart tracks Kalvista Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Kalvista Pharmaceuticals Inc (2018–2018)
Year-by-year Capital Reinvestment Ratio for Kalvista Pharmaceuticals Inc from 2018 to 2018. For live market cap and broader valuation context, see KALV company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.14x | $10.56 Million | $1.43 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow